Great Lakes Wire

Michigan Attorney General Dana Nessel, alongside a coalition of 50 states and territories, has announced cooperation agreements and settlements with Heritage Pharmaceuticals and Apotex. The settlements, amounting to $49.1 million, address allegations that the companies engaged in conspiracies to inflate drug prices, reduce competition, and restrain trade concerning generic prescription drugs.

The agreements include commitments from both companies to assist in ongoing multistate litigations against other pharmaceutical entities accused of similar actions. Additionally, Heritage and Apotex have agreed to implement internal reforms to promote fair competition and adherence to antitrust laws.

A motion for preliminary approval of the $10 million settlement with Heritage has been filed in the United States District Court for the District of Connecticut. The $39.1 million settlement with Apotex awaits necessary signatures from involved states and territories before finalization.

These developments occur as preparations are underway for an upcoming trial in Hartford, Connecticut. Nessel stated: “Those who depend on reasonably priced pharmaceuticals to manage their health suffer when corporations collude to manipulate generic drug prices.” She emphasized that unethical behavior prioritizing profits over people will not be tolerated.

Consumers who purchased generic drugs from Heritage or Apotex between 2010 and 2018 may qualify for compensation. For eligibility inquiries, individuals can call 1-866-290-0182 or visit the Attorneys General Generic Drugs Settlement website.

Joining Michigan in this announcement are attorneys general from various states including Alaska, Arizona, California, Colorado, Delaware, Florida, Georgia, Illinois, New York among others.